Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Quotes

Analysis

Analyst Ratings

News

Press Releases

Twitter

Media Mentions

Ownership

Earnings

Merck & Company, Inc. (MRK) 47.44 -0.17
Price Open:47.05Day's Range:40.12000 - 48.78500
Price Close:47.3352wk Range:32.19 - 48.78500
Price Day Change:-0.17Volume:15,795,941
Price % Change:-0.36Market Cap:142.4B
Bid:47.13000PE Ratio:24.15
Ask:47.44000EPS Diluted:1.96
Trade MRK NOW!

The Latest On MRK

Merck Issues Update on Phase III Trial for Preladenant 5/23/13 5:00pm
Merck Issues Statement on FDA Advisory Committee Meeting Results for Suvorexant 5/22/13 8:24pm
PreMarket Info Recap for May 22, 2013 5/22/13 9:17am
Short Interest in Vertex Rises, in Celgene Falls 5/11/13 10:45am
Merck Announces FDA Acceptance of Biologics License Application for Investigational Ragweed Pollen Sublingual Allergy Immunotherapy Tablet 5/8/13 8:32am
Barron's Recap: Apple Tops the Barron's 500 5/6/13 6:32am
UPDATE: Fitch Affirms Ratings on Merck; Outlook Lowered from Positive to Negative 5/3/13 10:24am
Earnings Trigger Volume Spike in Pharma ETF 5/1/13 2:41pm
May 1st Watchlist 5/1/13 9:37am
UPDATE: Merck Posts 8.3% Drop In Q1 Profit, Lowers Forecast 5/1/13 7:34am
Merck Announces New $15B Share Repurchase Program 5/1/13 7:00am
Pfizer Tanks on Earnings, Unhealthy Guidance 4/30/13 10:36am
more
Press Releases
Merck Provides Update on Phase III Clinical Program for Preladenant, the Company's Investigational Parkinson's Disease Medicine 5/23/13 Business Wire
Merck Statement on FDA Advisory Committee Meeting for Suvorexant 5/22/13 Business Wire
Critical Alerts For HSBC, Merck, CSX, Wynn Resorts, and Lam Research Released By InvestorsObserver 5/22/13 Newswire
Merck Announces $5 Billion Accelerated Share Repurchase 5/21/13 Business Wire
Merck to Present at the UBS Global Healthcare Conference 5/17/13 Business Wire
Merck to Present at the Bank of America/Merrill Lynch 2013 Healthcare Conference 5/14/13 Business Wire
Sanford Heisler Files $100m+ Discrimination Suit Against Pharma Giant Merck & Co., Inc. 5/9/13 Newswire
GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], Merck's HPV Vaccine, Available to Developing Countries through UNICEF Tender 5/9/13 Business Wire
Merck Announces FDA Acceptance of Biologics License Application for Investigational Ragweed Pollen Sublingual Allergy Immunotherapy Tablet 5/8/13 Business Wire
Merck and Celebrity Chef Art Smith "Cook Up a Recipe" for Better Type 2 Diabetes Management 5/7/13 Newswire
Merck Consumer Care Launches Health and Wellness Effort To Help Empower Moms To Live A More Active Lifestyle With Their Families 5/6/13 Newswire
ADDING MULTIMEDIA: FDA Approves Merck's LIPTRUZET™ (ezetimibe and atorvastatin), a New Product That Can Help Powerfully Lower LDL Cholesterol 5/6/13 Business Wire

Get the latest MRK stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Merck & Company, Inc. stock price.

Partner Headlines
Leon Cooperman's First Quarter Increases 5/24/13
Dow's Top Performers :PG, WMT, CSCO 5/24/13
Approaching Resistance: Merck 5/23/13
Merck Enters into Strategic Deal - Analyst Blog 5/22/13
Don't Follow Me, I'm Lost: Stock Buybacks 5/22/13
Stock Market News for May 22, 2013 - Market News 5/22/13
Merck Is Close to its 50 Day Moving Average 5/22/13
MERCK 5/21/13
Roche, Reloaded 5/21/13
After A Big Rally, Pfizer Might Need Some Rest 5/21/13
Worst Performing Dow Component: Cisco 5/20/13
Trading Idea: Momentum Building in Merck 5/20/13